Table 1. Heterogenous vancomycin intermediate Staphylococcus aureus strains and their corresponding patients in this study.

Specimen No	Age	Gender	Primary diagnosis	Specimen	Diabetes mellitus	Renal failure	Malignancy	Admission to ICU	Days of hospital stay	Days of IV VCM	On Beta-lactam	Area under curve Ratio8
682	14	Male	Right hip osteomyelitis	Nasal swab	No	No	No	Yes	44 days	0	Yes	0.90
582	53	Female	Left diabetic foot ulcer	Pus swab	Yes	Yes	No	Yes	52 days	14	Yes	0.93
182	58	Male	Acute ventriculitis	CSF	Yes	No	No	Yes	98 days	14	Yes	1.01
252	20	Male	Gluteal sarcoma with HAP	Sputum	No	No	Yes	Yes	24 days	10	Yes	0.90
978	71	Male	Pemphigus folliaceous	Pus swab	Yes	No	No	No	34 days	7	Yes	1.01
215	4	Female	Acute encephalitis with HAP	Tracheal aspirate	No	No	No	Yes	32 days	14	Yes	0.96
460	29	Female	Meningo-encephalitis with HAP	Sputum	No	No	No	Yes	38 days	10	Yes	0.98

ICU, intensive care unit; IV, intravenous; VCM, vancomycin; CSF, cerebrospinal fluid; HAP, hospital acquired pneumonia.